Lipocine (LPCN)

Lipocine (LPCN) Financial Statements


Lipocine Financial Overview

Lipocine's market cap is currently ―. The company's EPS TTM is $-2.336; its P/E ratio is -1.28; Lipocine is scheduled to report earnings on November 8, 2023, and the estimated EPS forecast is $-0.60. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue-$ 55.00K-$ 0.00$ 500.00K
Gross Profit-$ 55.00K-$ -2.10M$ -2.40M
EBIT$ -3.55M$ -3.87M$ -2.53M$ -2.41M$ -2.62M
EBITDA$ -3.79M$ -4.12M$ -2.68M$ -2.41M$ -2.62M
Net Income Common Stockholders$ -3.55M$ 4.92M$ -2.23M$ -2.41M$ -2.63M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 25.79M$ 28.87M$ 32.53M$ 34.26M$ 37.40M
Total Assets$ 30.48M$ 34.02M$ 37.54M$ 39.42M$ 42.19M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -25.79M$ -28.87M$ -32.53M$ -34.26M$ -37.40M
Total Liabilities$ 1.83M$ 1.93M$ 1.91M$ 1.78M$ 2.30M
Stockholders Equity$ 28.66M$ 32.09M$ 35.63M$ 37.65M$ 39.89M
Cash Flow-
Free Cash Flow$ -3.31M$ -3.93M$ -1.94M$ -3.20M$ -3.06M
Operating Cash Flow$ -3.31M$ -3.93M$ -1.84M$ -3.20M$ -3.05M
Investing Cash Flow$ 3.56M$ 5.55M$ 2.60M$ 613.90K$ 3.79M
Financing Cash Flow$ -5.20K$ -6.02K$ -5.90K$ 44.00$ -1.49M
Currency in USD

Lipocine Earnings and Revenue History

Lipocine Debt to Assets

Lipocine Cash Flow

Lipocine Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis